SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-000503
Filing Date
2019-01-04
Accepted
2019-01-04 16:02:34
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4182
  Complete submission text file 0000899243-19-000503.txt   5727
Mailing Address 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301
Business Address
Topper James N (Reporting) CIK: 0001341382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 19509961

Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations